The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome

BACKGROUND: Multicentric Castleman disease (MCD) is an uncommon lymphoproliferative disease characterized by systemic inflammatory reactions associated with the dysregulated production of interleukin-6 (IL-6). In patients with MCD, renal involvement is uncommon, with only one report published regard...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunami, Masatoshi, Ubara, Yoshifumi, Sumida, Keiichi, Oshima, Yoichi, Oguro, Masahiko, Kinoshita, Kazuya, Tanaka, Kiho, Nakamura, Yuki, Kinowaki, Keiichi, Ohashi, Kenichi, Fujii, Takeshi, Igawa, Takuro, Sato, Yasuharu, Ishii, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186080/
https://www.ncbi.nlm.nih.gov/pubmed/30314457
http://dx.doi.org/10.1186/s12882-018-1065-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186080/
https://www.ncbi.nlm.nih.gov/pubmed/30314457
http://dx.doi.org/10.1186/s12882-018-1065-4

Ejemplares similares